A5091982616- Bladder and Urothelial Cancer Treatments
- Urinary and Genital Oncology Studies
- Renal cell carcinoma treatment
- Prostate Cancer Treatment and Research
- Economic and Financial Impacts of Cancer
- Blood properties and coagulation
- Health Systems, Economic Evaluations, Quality of Life
- Infectious Disease Case Reports and Treatments
- Clinical Reasoning and Diagnostic Skills
- Social Media in Health Education
- Multiple and Secondary Primary Cancers
- Primary Care and Health Outcomes
- Metastasis and carcinoma case studies
- Adrenal and Paraganglionic Tumors
- Healthcare cost, quality, practices
- Esophageal Cancer Research and Treatment
- Total Knee Arthroplasty Outcomes
- Hip disorders and treatments
- Healthcare Policy and Management
- Adipokines, Inflammation, and Metabolic Diseases
- Colorectal Cancer Screening and Detection
- Inflammatory Biomarkers in Disease Prognosis
- Immunotherapy and Immune Responses
- Orthopaedic implants and arthroplasty
- Pituitary Gland Disorders and Treatments
George Washington University
2023-2024
George Washington University Hospital
2023
As a composite immunonutritional biomarker, the Hemoglobin, Albumin, Lymphocyte, Platelet (HALP) score has shown promise in assessing patient's overall health status by integrating several routinely collected laboratory indicators. This biomarker been examined many different populations of patients and disease states (i.e., cancer), but an integrated, universal rubric using standardized thresholds not thus far developed. Pre-existing large population-based databases represent ideal source to...
Background: Muscle-invasive bladder cancer (MIBC) is a potentially fatal disease, especially in the setting of locally advanced or node-positive disease. Adverse outcomes have also primarily been associated with low-income status, as has reported other cancers. While adoption neoadjuvant cisplatin-based chemotherapy (NAC) followed by radical cystectomy (RC) and pelvic lymph node dissection (PLND) improved outcomes, these standard-of-care treatments may be underutilized lower-income patients....
Adrenal cavernous hemangiomas are rare benign vascular tumors that pose significant diagnostic challenges. Despite their nature, features overlapping with malignancies often complicate management decisions.A 64-year-old male presented a 4.4 cm necrotic left adrenal mass discovered incidentally on imaging. His medical history included papillary thyroid carcinoma, subsequent thyroidectomy and radioactive iodine ablation. Evaluations for hiccups revealed multiple lung nodules, hypertrophic...
You have accessJournal of UrologyBladder Cancer: Epidemiology & Evaluation I (MP08)1 May 2024MP08-18 METASTATIC BEHAVIOR OF UROTHELIAL CARCINOMA VARIANT HISTOLOGY: A COMPREHENSIVE NCDB ANALYSIS Arthur P. Drouaud, Vincent E. Xu, Ryan M. Antar, Alejandro Velasquez, and Michael J. Whalen DrouaudArthur Drouaud , XuVincent Xu AntarRyan Antar VelasquezAlejandro Velasquez WhalenMichael View All Author Informationhttps://doi.org/10.1097/01.JU.0001008780.87855.57.18AboutPDF ToolsAdd to...
You have accessJournal of UrologyBladder Cancer: Invasive II (MP22)1 May 2024MP22-06 INCOME DISPARITIES IN SURVIVAL AND RECEIPT OF NEOADJUVANT CHEMOTHERAPY LYMPH NODE DISSECTION FOR MUSCLE-INVASIVE BLADDER CANCER Ryan M. Antar, Vincent E. Xu, Arthur Drouaud, Olivia F. Gordon, Sarah Azari, Briana Goddard, Sean Tafuri, and Michael J. Whalen AntarRyan Antar , XuVincent Xu DrouaudArthur Drouaud GordonOlivia Gordon AzariSarah Azari GoddardBriana Goddard TafuriSean Tafuri WhalenMichael View All...
Urology is one of the most competitive specialties in medicine, creating a challenge for prospective students looking to secure residency position. Our study aims assess online interest urology by querying interaction with search terms and criteria programs. Utilizing Google Trends analysis from 2011 2024, this examined urology-related volume indexes, as well temporal geographical patterns. Furthermore, number positions American Urological Association database 2022 match process was...
e16620 Background: UTUC is a rare malignancy with poorer prognosis compared to bladder urothelial carcinoma. Radical nephroureterectomy (RNU) remains the standard treatment for high-risk UTUC. Considering decline in renal function RNU and promising pathologic complete response rates from phase II trial ECOG-ACRIN 8141, NAC has emerged as favored perioperative regimen chemo-eligible patients However, RCTs exploring NAC's efficacy are absent, large-scale studies examining role predictors its...
Partial cystectomy (PC) offers potential benefits for select patients with muscle-invasive bladder cancer (MIBC). However, the oncologic efficacy of PC may be compromised due to underutilization standard-of-care modalities, such as neoadjuvant chemotherapy (NAC) and pelvic lymph node dissection (PLND). We aimed assess factors influencing incorporation NAC PLND evaluate their impact on overall survival (OS).
Introduction: Prostate cancer (PCa) is the second leading cause of mortality in US males, with metastatic disease (mPCa) comprising 5% cases. This represents an incurable and uniformly lethal disease. Thus, novel therapeutic approaches are needed. Cytoreductive surgery setting has become commonplace for renal cell carcinoma, definitive local radiotherapy been employed oligometastatic prostate via STAMPEDE trial. study further explores use treatment pelvic or radical prostatectomy along...
4565 Background: The incidence of metastatic renal cell carcinoma (mRCC) is rising globally in both males and females. Previous studies have shown that females with mRCC experience better overall survival (OS) when compared to males. In the era immunotherapy (IM) as part standard care, gender-based outcome disparities are unclear. this study, we identify gender-specific trends treatment regimen OS. Methods: National Cancer Database (NCDB) was queried from 2004 2019 for a retrospective cohort...